{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:45:02Z","timestamp":1794573902412,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>At a recent consensus conference, the Malignant Hyperthermia Association of the United States addressed 6 important and unresolved clinical questions concerning the optimal management of patients with malignant hyperthermia (MH) susceptibility or acute MH. They include: (1) How much dantrolene should be available in facilities where volatile agents are not available or administered, and succinylcholine is only stocked on site for emergency purposes? (2) What defines masseter muscle rigidity? What is its relationship to MH, and how should it be managed when it occurs? (3) What is the relationship between MH susceptibility and heat- or exercise-related rhabdomyolysis? (4) What evidence-based interventions should be recommended to alleviate hyperthermia associated with MH? (5) After treatment of acute MH, how much dantrolene should be administered and for how long? What criteria should be used to determine stopping treatment with dantrolene? (6) Can patients with a suspected personal or family history of MH be safely anesthetized before diagnostic testing? This report describes the consensus process and the outcomes for each of the foregoing unanswered clinical questions.<\/jats:p>","DOI":"10.1213\/ane.0000000000004039","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T21:20:03Z","timestamp":1551475203000},"page":"652-659","source":"Crossref","is-referenced-by-count":37,"title":["Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia"],"prefix":"10.1213","volume":"128","author":[{"given":"Ronald S.","family":"Litman","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria I.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Drexel University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn Green","family":"Larach","sequence":"additional","affiliation":[{"name":"The North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States at the Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Mayes","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanad","family":"Shukry","sequence":"additional","affiliation":[{"name":"Division of Pediatric Anesthesiology, Department of Anesthesiology, Children\u2019s Hospital & Medical Center, Omaha, Nebraska"},{"name":"University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Theroux","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Alfred I. duPont Hospital for Children, Wilmington, Delaware"},{"name":"Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Watt","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University at Buffalo School of Medicine, Kaleida Health, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, University of Iowa, Iowa City, Iowa."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","article-title":"Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.","volume":"118","author":"Riazi","year":"2014","journal-title":"Anesth Analg"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1213\/ANE.0000000000000421","article-title":"Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.","volume":"119","author":"Larach","year":"2014","journal-title":"Anesth Analg"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.","volume":"9","author":"Klingler","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R8-20230812","first-page":"161","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility.","volume":"65","author":"Rosenberg","year":"1986","journal-title":"Anesth Analg"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000542-199406000-00009","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.","volume":"80","author":"O\u2019Flynn","year":"1994","journal-title":"Anesthesiology"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03007480","article-title":"Malignant hyperthermia susceptibility in adult patients with masseter muscle rigidity.","volume":"37","author":"Allen","year":"1990","journal-title":"Can J Anaesth"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF03005790","article-title":"Malignant hypertonic hyperpyrexia syndrome.","volume":"16","author":"Gibson","year":"1969","journal-title":"Can Anaesth Soc J"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00000542-198710000-00003","article-title":"The effects of succinylcholine on mouth opening.","volume":"67","author":"Van der Spek","year":"1987","journal-title":"Anesthesiology"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1213\/00000539-198908000-00003","article-title":"Effects of succinylcholine at the masseter and adductor pollicis muscles in adults.","volume":"69","author":"Smith","year":"1989","journal-title":"Anesth Analg"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03007477","article-title":"Dose-related effects of succinylcholine on the adductor pollicis and mass\u00e9ter muscles in children.","volume":"37","author":"Plumley","year":"1990","journal-title":"Can J Anaesth"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/00000542-198812000-00052","article-title":"Underdosage with succinylcholine may lead to incorrect diagnosis of masseter spasm in children.","volume":"69","author":"Meakin","year":"1988","journal-title":"Anesthesiology"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/bja\/65.6.816","article-title":"Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children.","volume":"65","author":"Meakin","year":"1990","journal-title":"Br J Anaesth"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia.","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00000542-198704000-00017","article-title":"Prediction of malignant hyperthermia susceptibility by clinical signs.","volume":"66","author":"Larach","year":"1987","journal-title":"Anesthesiology"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000542-198710000-00001","article-title":"Trismus is not trivial.","volume":"67","author":"Rosenberg","year":"1987","journal-title":"Anesthesiology"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00000542-197810000-00020","article-title":"Implications of masseter spasm after succinylcholine.","volume":"49","author":"Donlon","year":"1978","journal-title":"Anesthesiology"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/bja\/62.5.540","article-title":"Is there a relationship between masseteric muscle spasm and malignant hyperpyrexia?","volume":"62","author":"Christian","year":"1989","journal-title":"Br J Anaesth"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1213\/00000539-199102000-00003","article-title":"Masseter muscle spasm in children: implications of continuing the triggering anesthetic.","volume":"72","author":"Littleford","year":"1991","journal-title":"Anesth Analg"},{"key":"R23-20230812","first-page":"1039","article-title":"Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures.","volume":"81","author":"Antognini","year":"1995","journal-title":"Anesth Analg"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.","volume":"18","author":"Petejova","year":"2014","journal-title":"Crit Care"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1034\/j.1399-6576.2003.00116.x","article-title":"Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.","volume":"47","author":"Farbu","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","article-title":"The myotonias and susceptibility to malignant hyperthermia.","volume":"109","author":"Parness","year":"2009","journal-title":"Anesth Analg"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjsm.2006.032516","article-title":"Is there a link between malignant hyperthermia and exertional heat illness?","volume":"41","author":"Hopkins","year":"2007","journal-title":"Br J Sports Med"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.CSMR.0000313392.79569.e7","article-title":"Exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia: is there a link?","volume":"7","author":"Muldoon","year":"2008","journal-title":"Curr Sports Med Rep"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1981.03320010023020","article-title":"Treatment of heat stroke with dantrolene.","volume":"246","author":"Lydiatt","year":"1981","journal-title":"JAMA"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000539-200109000-00030","article-title":"A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia.","volume":"93","author":"Bendahan","year":"2001","journal-title":"Anesth Analg"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice.","volume":"133","author":"Durham","year":"2008","journal-title":"Cell"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"e0135496","DOI":"10.1371\/journal.pone.0135496","article-title":"Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?","volume":"10","author":"Sagui","year":"2015","journal-title":"PLoS One"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0140-6736(91)92304-K","article-title":"Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.","volume":"338","author":"Hopkins","year":"1991","journal-title":"Lancet"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","article-title":"Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.","volume":"94","author":"Wappler","year":"2001","journal-title":"Anesthesiology"},{"key":"R35-20230812","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0960-8966(93)90114-Y","article-title":"Pathological findings in 165 patients explored for malignant hyperthermia susceptibility.","volume":"3","author":"Figarella-Branger","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1399-0004.2009.01251.x","article-title":"The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility.","volume":"76","author":"Sambuughin","year":"2009","journal-title":"Clin Genet"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/bja\/aew047","article-title":"Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test.","volume":"116","author":"Roux-Buisson","year":"2016","journal-title":"Br J Anaesth"},{"key":"R38-20230812","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"R39-20230812","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/88.4.508","article-title":"Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees.","volume":"88","author":"Davis","year":"2002","journal-title":"Br J Anaesth"},{"key":"R40-20230812","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","article-title":"Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.","volume":"112","author":"Capacchione","year":"2010","journal-title":"Anesthesiology"},{"key":"R41-20230812","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","article-title":"Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families.","volume":"115","author":"Groom","year":"2011","journal-title":"Anesthesiology"},{"key":"R42-20230812","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0952-8180(96)00207-3","article-title":"Sudden unexplained death in a patient with a family history of malignant hyperthermia.","volume":"9","author":"Ryan","year":"1997","journal-title":"J Clin Anesth"},{"key":"R43-20230812","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke.","volume":"286","author":"Tobin","year":"2001","journal-title":"JAMA"},{"key":"R44-20230812","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jemermed.2016.03.002","article-title":"Is it exertional heatstroke or something more? A case report.","volume":"51","author":"Reske-Nielsen","year":"2016","journal-title":"J Emerg Med"},{"key":"R45-20230812","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0310057X9802600317","article-title":"Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia.","volume":"26","author":"K\u00f6chling","year":"1998","journal-title":"Anaesth Intensive Care"},{"key":"R46-20230812","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/imj.12498","article-title":"Fever-induced recurrent rhabdomyolysis due to a novel mutation in the ryanodine receptor type 1 gene.","volume":"44","author":"Molenaar","year":"2014","journal-title":"Intern Med J"},{"key":"R47-20230812","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nmd.2016.06.001","article-title":"217th ENMC International Workshop: RYR1-related myopathies, Naarden, The Netherlands, 29-31 January 2016.","volume":"26","author":"Jungbluth","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"R49-20230812","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00000542-200009000-00010","article-title":"Core cooling by central venous infusion of ice-cold (4 degrees C and 20 degrees C) fluid: isolation of core and peripheral thermal compartments.","volume":"93","author":"Rajek","year":"2000","journal-title":"Anesthesiology"},{"key":"R50-20230812","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/00000542-200405000-00005","article-title":"Effects of a circulating-water garment and forced-air warming on body heat content and core temperature.","volume":"100","author":"Taguchi","year":"2004","journal-title":"Anesthesiology"},{"key":"R51-20230812","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000542-199711000-00013","article-title":"Efficacy of intraoperative cooling methods.","volume":"87","author":"Plattner","year":"1997","journal-title":"Anesthesiology"},{"key":"R52-20230812","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1213\/ANE.0000000000002691","article-title":"Heating and cooling rates with an esophageal heat exchange system.","volume":"126","author":"Kalasbail","year":"2018","journal-title":"Anesth Analg"},{"key":"R53-20230812","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.anes.0000265148.86566.68","article-title":"Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.","volume":"106","author":"Burkman","year":"2007","journal-title":"Anesthesiology"},{"key":"R54-20230812","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1213\/ANE.0000000000001054","article-title":"Prevalence of malignant hyperthermia diagnosis in New York State Ambulatory Surgery Center Discharge Records 2002 to 2011.","volume":"122","author":"Lu","year":"2016","journal-title":"Anesth Analg"},{"key":"R55-20230812","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1213\/ANE.0b013e318213fad7","article-title":"Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.","volume":"112","author":"Birgenheier","year":"2011","journal-title":"Anesth Analg"},{"key":"R56-20230812","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1213\/ANE.0b013e3182a8fad0","article-title":"Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry.","volume":"118","author":"Nelson","year":"2014","journal-title":"Anesth Analg"},{"key":"R57-20230812","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","article-title":"Malignant hyperthermia susceptibility and related diseases.","volume":"128","author":"Litman","year":"2018","journal-title":"Anesthesiology"},{"key":"R58-20230812","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/ALN.0000000000000256","article-title":"Malignant hyperthermia in the ambulatory surgery center: how should we prepare?","volume":"120","author":"Litman","year":"2014","journal-title":"Anesthesiology"},{"key":"R59-20230812","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1213\/ANE.0b013e3182373b4a","article-title":"Creation of a guide for the transfer of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities.","volume":"114","author":"Larach","year":"2012","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201904000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:21:13Z","timestamp":1786112473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201904000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004039","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}